However, combination of P1446A with the BH3-mimetic ABT-737, a BCL2/X inhibitor, partially reversed CD40L-mediated protection of CLL cells (Fig 5D). The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.